Inflammatory signaling in cartilage:: MAPK and NF-κB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis

被引:141
作者
Saklatvala, Jeremy [1 ]
机构
[1] Imperial Coll London, Kennedy Inst Rheumatol, London W6 8LH, England
基金
英国医学研究理事会;
关键词
chondrocyte; MAP kinase; NF-kappa B; matrix metalloproteinase; protein kinase; protein kinase inhibitor; inflammatory response; osteoarthritis;
D O I
10.2174/138945007779940115
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Osteoarthritis is characterised by degeneration of articular cartilage. It is thought to be primarily a disease of cartilage. Inflammatory response genes, such as proteinases, cyclooxygenase, and cytokines are implicated in its pathogenesis. The evidence for expression of these genes in articular cartilage in osteoarthritis is reviewed. The expression of inflammatory response genes is controlled by four major intracellular signalling pathways. These lead to activation of the three mitogen-activated protein kinases (MAPK) and the transcriptional regulator nuclear factor kappa (NF kappa)-B. The current state of knowledge of the structure of these pathways is summarized. Pharmacological inhibitors of the protein kinases of the pathways in current use are described, and insights into chondrocyte gene expression obtained with them are discussed. Very limited use of these inhibitors has yet been made in animal models of osteoarthritis.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 106 条
[21]   AS601245 (1,3-benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4 pyrimidinyl) acetonitrile):: A c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties [J].
Carboni, S ;
Hiver, A ;
Szyndralewiez, C ;
Gaillard, P ;
Gotteland, JP ;
Vitte, PA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (01) :25-32
[22]   Novel IKK inhibitors:: β-carbolines [J].
Castro, AC ;
Dang, LC ;
Soucy, F ;
Grenier, L ;
Mazdiyasni, H ;
Hottelet, M ;
Parent, L ;
Pien, C ;
Palombella, V ;
Adams, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (14) :2419-2422
[23]   INTERLEUKIN-1 AND ONCOSTATIN-M IN COMBINATION PROMOTE THE RELEASE OF COLLAGEN FRAGMENTS FROM BOVINE NASAL CARTILAGE IN CULTURE [J].
CAWSTON, TE ;
ELLIS, AJ ;
HUMM, G ;
LEAN, E ;
WARD, D ;
CURRY, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 215 (01) :377-385
[24]   TRANSFORMING GROWTH FACTOR-BETA IS A POTENT INHIBITOR OF IL-1 INDUCED PROTEASE ACTIVITY AND CARTILAGE PROTEOGLYCAN DEGRADATION [J].
CHANDRASEKHAR, S ;
HARVEY, AK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 157 (03) :1352-1359
[25]   MINDS, MEMES, AND RHETORIC [J].
CLARK, SRL .
INQUIRY-AN INTERDISCIPLINARY JOURNAL OF PHILOSOPHY, 1993, 36 (1-2) :3-16
[26]   The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs) [J].
Clerk, A ;
Sugden, PH .
FEBS LETTERS, 1998, 426 (01) :93-96
[27]   Tpl2/Cot signals activate ERK, JNK, and NF-κB in a cell-type and stimulus-specific manner [J].
Das, S ;
Cho, J ;
Lambertz, I ;
Kelliher, MA ;
Eliopoulos, AG ;
Du, KY ;
Tsichlis, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) :23748-23757
[28]  
DeSilva DR, 1998, J IMMUNOL, V160, P4175
[29]   Characterization and quantitation of NF-κB nuclear translocation induced by interleukin-1 and tumor necrosis factor-α -: Development and use of a high capacity fluorescence cytometric system [J].
Ding, GJF ;
Fischer, PA ;
Boltz, RC ;
Schmidt, JA ;
Colaianne, JJ ;
Gough, A ;
Rubin, RA ;
Miller, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) :28897-28905
[30]   A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE [J].
DUDLEY, DT ;
PANG, L ;
DECKER, SJ ;
BRIDGES, AJ ;
SALTIEL, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7686-7689